Three design aspects for high quality post-marketing cohort studies

BMJ. 2017 Apr 12:357:j1851. doi: 10.1136/bmj.j1851.

Authors

Michael Fralick¹, Aaron S Kesselheim¹

Affiliation

¹ Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02120, USA.

PMID: 28404570
DOI: 10.1136/bmj.j1851

No abstract available

Publication types

Letter
Comment

MeSH terms

Cohort Studies
Marketing*
Product Surveillance, Postmarketing*